Dr. Michal Besser

The Besser lab is specialized in the clinical production of CAR T cells and Tumor Infiltrating Lymphocytes (TIL) for therapy of cancer patients.

Adoptive cell therapy serves as a platform for a wide range of research projects, which mainly seek the understanding and improvement of cellular therapies and immunotherapy. 
Research activities include among others the development of off-the-shelf CAR T cells, new constructs for CAR T cells, identification of neo-antigen reactive T cells and the search for predictive markers of clinical response.  

Contact Information:

Dr. Michal Besser PhD
Sheba Medical Center


Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive